Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has necessarily ...
AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...
As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...
A new datamine of Borderlands 4 provides some some pretty compelling evidence of the next DLC Vault Hunter coming in Story ...
According to TipRanks.com, Blum is a 4-star analyst with an average return of 9.1% and a 40.2% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., ...
The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...
While the confident stride through life with unexamined certainty, those who truly know themselves are caught in an endless ...
Jayne Ann Phillips looks back without imposing a moral; Maria Semple keeps things moving before one can form. A memoir and a ...
Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...
This made my homelab way more interesting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results